Clinical Trial Update: Safety of hLF1-11 for the Treatment of Infectious Complications Among HSCT Recipients [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating the safety of the lactoferrin-derived peptide hLF1-11 for infectious complications in hematopoietic stem cell transplant recipients…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Infection
• Fungal Infection

Drugs mentioned

• hLF1-11 (hLF1-11)

Snippet

Sponsor: AM-Pharma | Conditions: Fungal Infection, Bacterial Infection | Phase 1, Phase 2 | Status: WITHDRAWN